Plasmodium falciparum apical membrane antigen 1 (PfAMA1) (AMA1)

Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a critical type I integral membrane protein found in the apical complex of malaria parasites [15, 16]. It is essential for the invasion of host erythrocytes by merozoites and hepatocytes by sporozoites, making it a primary target for malaria vaccine development [9, 17]. AMA1 is initially stored in the micronemes and translocated to the parasite surface just before invasion, where it interacts with rhoptry neck protein 2 (RON2) to form a 'moving junction' that facilitates entry into the host cell [16]. The specific peptide AMA49-C1 is a 49-amino acid synthetic cyclic mimetic of the semi-conserved loop I of domain III of AMA1, designed to elicit invasion-blocking antibodies [7, 12]. While AMA1 is highly immunogenic, its extreme genetic polymorphism allows the parasite to evade strain-specific immune responses, posing a significant challenge for the creation of a broadly effective vaccine [1, 18]. Therapeutic strategies include recombinant protein vaccines like AMA1-C1 and peptide-based virosomal formulations like PEV301 [4, 6].

Other names

Apical membrane antigen 1PfAMA1Merozoite surface protein AMA1AMA49-C1AMA1-C1

Inhibition of the interaction between AMA1 and rhoptry neck protein 2 (RON2), which prevents the formation of the moving junction and subsequent parasite invasion of host cells.